GameStop CEO Ryan Cohen proposes a $56 billion buyout of eBay at a 20% premium. The bold move aligns with his vision to grow GameStop to $100 billion amid huge personal incentives.
Tap a lens to see what this story means for you.
Liked this? The Brief brings you the whole day in tech, verified, every morning.
Two minutes, free forever. What's in The Brief →
See what’s happening right now
The Feed runs all day — short, verified briefs the moment they break.
Open the FeedFollow @thecircuitry_
Every story we publish, as it happens. No noise between.
Reader-supported
The Circuitry is a passion project I've always wanted to build, and I love the work behind it.
Running it costs real money. APIs, hosting, time. To keep improving the site and growing this into something useful for everyone, those costs have to be covered.
Any contribution is appreciated. If not, no pressure. Thanks for reading.
Bitcoin Magazine reports that Payward, parent of Kraken, signed a definitive agreement to buy Saldo Finance Oy and its banking subsidiary, securing an EU license spanning five markets. Closing is targeted for 2027 and would support deposit interest, loans, credit cards and banking-as-a-service products.
Nvidia is in early talks to acquire Reflection AI or invest more in the open-weight model startup, the Financial Times reported. Bloomberg reported talks on a bigger investment or computing deal, with no terms agreed. Nvidia has already invested $800 million, the FT said.
Advanced Micro Devices plans to buy World Labs for roughly US$8.2 billion using stock only. This acquisition provides access to 3D modeling technology meant to inform the development of new hardware, software, and systems.
Stripe has finalized an agreement to acquire AI gateway startup OpenRouter for more than $7 billion according to Bloomberg. The deal values the company far above its $1.3 billion valuation from a May funding round and brings a platform with 8 million users and access to over 400 models into Stripe's portfolio.
Repligen will acquire BioLife Solutions for $1.5 billion, merging two longtime providers of tools for cell and gene therapy and biopreservation. The deal values BioLife shares at $31 each and is slated to close in the fourth quarter pending approvals.
